about
Prophylactic effect of a therapeutic vaccine against TB based on fragments of Mycobacterium tuberculosisGranuloma encapsulation is a key factor for containing tuberculosis infection in minipigsOral Administration of Heat-Killed Mycobacterium manresensis Delays Progression toward Active Tuberculosis in C3HeB/FeJ Mice.The scavenger protein apoptosis inhibitor of macrophages (AIM) potentiates the antimicrobial response against Mycobacterium tuberculosis by enhancing autophagy.Draft Genome Sequences of Mycobacterium setense Type Strain DSM-45070 and the Nonpathogenic Strain Manresensis, Isolated from the Bank of the Cardener River in Manresa, Catalonia, SpainTo achieve an earlier IFN-γ response is not sufficient to control Mycobacterium tuberculosis infection in mice.Low dose aerosol fitness at the innate phase of murine infection better predicts virulence amongst clinical strains of Mycobacterium tuberculosisMultiple consecutive infections might explain the lack of protection by BCG.Comparative evaluation of the new version of the INNO-LiPA Mycobacteria and genotype Mycobacterium assays for identification of Mycobacterium species from MB/BacT liquid cultures artificially inoculated with Mycobacterial strainsWidespread bronchogenic dissemination makes DBA/2 mice more susceptible than C57BL/6 mice to experimental aerosol infection with Mycobacterium tuberculosisIndividual-Based Modeling of Tuberculosis in a User-Friendly Interface: Understanding the Epidemiological Role of Population Heterogeneity in a City.Local Inflammation, Dissemination and Coalescence of Lesions Are Key for the Progression toward Active Tuberculosis: The Bubble ModelInduction of a specific strong polyantigenic cellular immune response after short-term chemotherapy controls bacillary reactivation in murine and guinea pig experimental models of tuberculosis.Enhanced gamma interferon responses of mouse spleen cells following immunotherapy for tuberculosis relapse.Tuberculin immunotherapy: its history and lessons to be learned.The lack of a big picture in tuberculosis: the clinical point of view, the problems of experimental modeling and immunomodulation. The factors we should consider when designing novel treatment strategies.Towards host-directed therapies for tuberculosis.Will we be treating tuberculosis with vaccines in the XXI century?Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis.Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI.Effectiveness and safety of a treatment regimen based on isoniazid plus vaccination with Mycobacterium tuberculosis cells' fragments: field-study with naturally Mycobacterium caprae-infected goats.Evolution of foamy macrophages in the pulmonary granulomas of experimental tuberculosis models.Noninvasive method for diagnosis of visceral leishmaniasis by a latex agglutination test for detection of antigens in urine samples.Chemo-enzymatic synthesis and glycosidase inhibitory properties of DAB and LAB derivatives.Catalase-peroxidase activity has no influence on virulence in a murine model of tuberculosis.[Morganella morgagnii septic arthritis].Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis.The tuberculin skin test increases the responses measured by T cell interferon-gamma release assays.Evolution and role of corded cell aggregation in Mycobacterium tuberculosis cultures.Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials.Rapid diagnosis of Staphylococcus aureus bacteremia using S. aureus PNA FISH.Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis.Chemoenzymatic synthesis, structural study and biological activity of novel indolizidine and quinolizidine iminocyclitols.Damaging role of neutrophilic infiltration in a mouse model of progressive tuberculosis.Usefulness of acr expression for monitoring latent Mycobacterium tuberculosis bacilli in 'in vitro' and 'in vivo' experimental models.Evaluation of a Legionella urinary antigen enzyme immunoassay for rapid detection of Legionella pneumophila in water samplesInmunodiagnóstico y biomarcadores en tuberculosisCan systems immunology lead tuberculosis eradication?Latent TB Infection (LTBI) – Mycobacterium tuberculosis pathogenesis and the dynamics of the granuloma battlegroundIntragranulomatous necrosis in pulmonary granulomas is not related to resistance against Mycobacterium tuberculosis infection in experimental murine models induced by aerosol
P50
Q28744312-27241C1C-2362-4BEE-A444-6586DDC801FCQ28748169-BFD2460D-EFE6-419F-87C9-20A55E24CCAFQ31037455-27A83D06-C51A-40FA-BD7D-97746BF30ACBQ31143734-07ABA6A4-5087-485D-8951-EFC59C443100Q33457148-A7A16B67-4564-48E1-85B4-383D8E7E3E50Q33800857-74AF6960-CF05-4D98-9065-101D74EBCBF6Q34123530-EB0B56D1-A362-4903-BC09-C345C606275AQ35150684-9C2358CA-A63D-45C0-91C8-3CD63436DB5FQ35717907-53E88776-CD15-4056-9358-E2E730D51D44Q36044574-04C238D4-C7CE-412A-A892-C9B785C33A34Q36453072-F54D641C-1D68-4465-BCD1-96A4F651434BQ36529912-A3C42394-A70A-4E39-9D05-02F01BFFB314Q36844900-0576C84F-E865-47C8-B479-EB34086E402DQ36974318-1D8789BF-10C0-4596-83BA-768550640ADFQ37628881-8E68A8E8-DDEE-4C30-A7FC-ACF23744B7C9Q38193087-427954B6-B055-48F1-9DDE-E7E35D2814C0Q38858468-C713EEB4-7ACB-4CD2-8D01-858425CCB305Q39199203-BC254A96-73C3-4CB1-9CA4-3A92134BE38BQ39427936-4626E761-E53A-4930-B4EC-2C41751B3804Q39935921-8774CCA5-CAD8-4CE6-BE62-9E5BDB401387Q39979986-06103EFA-FAE1-4E8C-B6D8-ABAA4D3243D7Q40015842-E3EAB589-69F8-4D2C-9526-64FD0A421A8EQ43212588-9F2690F8-BE60-4C89-BD63-A53614327FBAQ44190053-E3B926D0-1B27-4E9C-9CCD-4F886E012C44Q44659067-02D5C45C-C0A5-43C4-97C1-22573519195AQ44760165-8E9837A9-00A3-4FF9-8B1A-AFA30B539D9AQ45231616-8221B4EE-08C8-4094-B80C-26514040849BQ46657592-627A0B94-3095-4C25-8851-09AC5DBBC388Q46803031-B9E336C1-EB6D-4A51-89F8-C25589C1A54AQ46851619-9FC45E39-F043-45AF-9D6A-597D0DB9005BQ51683016-A9BBD6F6-67A0-43FF-86E2-76A525104282Q53722156-AC50E6E6-F61A-448F-AC88-C117C66ACB8FQ54333711-27DB9E80-1025-4E80-A8CA-8E1B0A93D8DCQ54511799-76E31CAC-CECA-4D51-B49F-11B458655114Q54596301-85C51024-5D25-4F0F-9C78-E3F6CA40EA29Q58924858-0232F0A6-9A6B-4503-B4AC-5EA4BA561406Q60364438-5CECBE38-6FD0-4A1C-A13F-A03CDC7B1C8AQ61735083-510168BC-CFA6-4037-9F85-46FE8DA58EF8Q62735976-2E59D0FC-4DB5-42FC-B4B7-5117AE59AA01Q62738185-602C35B0-10CC-46D9-947C-C7779D4A18C0
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Cristina Vilaplana
@ast
Cristina Vilaplana
@en
Cristina Vilaplana
@es
Cristina Vilaplana
@nl
Cristina Vilaplana
@sl
type
label
Cristina Vilaplana
@ast
Cristina Vilaplana
@en
Cristina Vilaplana
@es
Cristina Vilaplana
@nl
Cristina Vilaplana
@sl
prefLabel
Cristina Vilaplana
@ast
Cristina Vilaplana
@en
Cristina Vilaplana
@es
Cristina Vilaplana
@nl
Cristina Vilaplana
@sl
P106
P21
P31
P496
0000-0002-2808-7270